Showing results (101-110 of 6,708) with videos related to
Sort By:
Pageof 671
Oncotargets and Therapy|January 7, 2022
Clinical Impact of Switching to Ceritinib After Severe AEs Related to Crizotinib/Alectinib in a Novel PTH2R-ALK Fusion Lung Adenocarcinoma: A Case ReportGang Shen, Yinping Du, Jifang Shen, et al.Oncotargets and Therapy|January 7, 2022
CBX7, a Potential Prognostic Biomarker in Lung AdenocarcinomaYanlong Yang, Zaoxiu Hu, Hongwen Sun, et al.Oncotargets and Therapy|December 8, 2021
Erratum: Expression of B7-H3 Correlates with PD-L1 and Poor Prognosis in Patients with Cervical Cancer [Corrigendum]Oncotargets and Therapy|January 20, 2022
Prognostic Implications of Six Altered Genes in Asian Non-Surgical Esophageal Carcinoma Patients Treated with ChemoradiotherapyAlei Feng, Ning Yang, Ruoying Yu, et al.Oncotargets and Therapy|April 25, 2017
Clinical significance of serum cathepsin B and cystatin C levels and their ratio in the prognosis of patients with esophageal cancerYan Yan, Kun Zhou, Liping Wang, et al.Oncotargets and Therapy|April 25, 2017
Serum galectin-1 in patients with multiple myeloma: associations with survival, angiogenesis, and biomarkers of macrophage activationMorten Nørgaard Andersen, Maja Ludvigsen, Niels Abildgaard, et al.Oncotargets and Therapy|April 25, 2017
The activity, safety, and evolving role of brigatinib in patients with ALK-rearranged non-small cell lung cancersJoshua K Sabari, Fernando C Santini, Alison M Schram, et al.Oncotargets and Therapy|April 25, 2017
Expression and significance of GRHL2 in esophageal cancerChengcheng Shao, Chushu Ji, Xiaoqiu Wang, et al.Oncotargets and Therapy|April 25, 2017
Therapeutic outcome of nasopharyngeal carcinoma with cranial nerve palsy: a single institution experience of 104 patientsChun-Chieh Huang, Fu-Min Fang, Hui-Chun Chen, et al.Pageof 671